Inhibition of Poly ADP-ribose polymerase 1 (PARP1) by either small interfering RNA or the PARP1 inhibitor AG-14361 results in upregulation of NKG2DL on the surface of patient-derived AML cells. This evidence concerns the gene PARP1 and acute myeloid leukemia.